Kimberly Guinan

6PUBLICATIONS
9CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 20, 2026
Health care resource use in the management of patients with relapsed/refractory diffuse large B-cell lymphoma - Canadian perspective.

|Sep 28, 2024
The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab.

Kimberly Guinan, Karine Mathurin, Jean Lachaine

|May 26, 2023
Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada.

Jean Lachaine, Kimberly Guinan, Andrew Aw

|Oct 27, 2022
Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost-Utility Analysis.

Kimberly Guinan, Karine Mathurin, Yunghan Au

|Sep 15, 2021
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada.

C Beauchemin, K Guinan, D Claveau

|Jan 13, 2021
Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada.

Jean Lachaine, Catherine Beauchemin, Kimberly Guinan

Pageof 1

Frequent Collaborators

3 joint publications

Versha Banerji

3 joint publications

Jean Lachaine

2 joint publications

Dipti Tankala

1 joint publications

C Beauchemin